Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE): An international, randomized, double-blind, placebo-controlled phase III clinical trial.
Paul Edward Goss
Honoraria - Novartis; Pfizer
Carlos H. Barrios
No relevant relationships to disclose
Richard Bell
Consultant or Advisory Role - Amgen
Research Funding - Amgen
Dianne M Finkelstein
No relevant relationships to disclose
Hiroji Iwata
No relevant relationships to disclose
Miguel Martin
Consultant or Advisory Role - Amgen; Genomic Health; Roche/Genentech
Ada H. Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Chunlei Ke
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Tapan Maniar
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Robert Edward Coleman
Consultant or Advisory Role - Novartis
Expert Testimony - Novartis